Searched for
REVENUE GROWTH PHARMA Q1
Buy, Sell or Hold: Goldman Sachs remains neutral on Tata Motors; Nuvama maintains buy on HULBrokerages show selective optimism amidst market jitters. Goldman Sachs backs Shyam Metalics & Energy with a 10% upside target, anticipatin...- Tata Motors PV shares plunge 10% after weaker than expected JLR FY27 guidanceTata Motors Passenger Vehicles shares dropped significantly. This followed Jaguar Land Rover's investor day where its financial outlook for...
- ChatGPT’s market share dips below 50%: Key AI trends to knowHit by Google Gemini's continued expansion and Claude's recent growth, ChatGPT's share of the AI assistant market fell below 50% for the fi...
- India Inc's sales growth gathers pace in March quarter, led by autos and metals: RBI dataManufacturing companies saw sales jump 14.5 percent in the fourth quarter of 2025-26. Automobiles, electrical machinery, and non-ferrous me...
- Tata Motors flags 'challenging & volatile' outlook for Jaguar Land RoverTata Motors Passenger Vehicles Limited saw record domestic sales in FY26. However, Jaguar Land Rover faced challenges impacting overall per...
- Automobiles, electrical machinery push sales of listed private manufacturing companies in Q4: RBI dataIndian manufacturing companies saw sales jump 14.5 percent in early 2026. Automobiles, electrical machinery, and metals led this growth. Ov...
- Nomura raises Adani Ports share price target by 12%. Here are 3 major reasons whyNomura has raised its target price on Adani Ports and Special Economic Zone to Rs 2,080 from Rs 1,850, while retaining its Buy rating. The ...
- Suzlon Energy shares jump over 6%. Why brokerages call it India’s most investible wind energy stock?Suzlon Energy shares rose sharply on Tuesday after the company outlined an ambitious FY31 roadmap focused on expanding beyond wind energy i...
- HCL Tech shares jump 3% after buying stake in Sarvam AI for Rs 1,427 croreHCL Tech share price gained 3% after i invested $150 million in Sarvam AI, India's largest AI startup, acquiring a 10.46% stake. This strat...
- Bonus bonanza! Last date to buy Brigade Enterprises shares for 1:3 bonus issue rewardBrigade Enterprises in May announced its first bonus issue in around seven years, along with the release of its Q4 results. It said its boa...
- Organised jewellers seen sustaining growth despite 80% surge in gold prices: NuvamaIndia's jewellery sector anticipates strong growth. Weddings and festivals are driving demand, even with high gold prices. Retailers report...
- Flexible office space market crosses 100 million sq ft mark, GCCs driving growthIndia's flexible workspace industry wrapped up FY26 on a high note, showcasing impressive double-digit revenue growth alongside rising prof...
- Explained: How SpaceX’s $75 billion IPO could create opportunity for Inox India shareholdersAs Elon Musk's SpaceX heads for a blockbuster IPO, investors are turning their attention to INOX India, a cryogenic technology specialist w...
- MTAR Tech shares crash 9% after 280% rally in a year. What’s spooking investors today?MTAR Technologies shares fell sharply after its key client, Bloom Energy, saw its stock tumble in the US market following the suspension of...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Honasa shares jump 6% on Rs 5,500 crore revenue target by FY31. What is Goldman Sachs saying?Honasa Consumer shares surged after the company outlined a revenue target of ₹5,500 crore by FY31. The guidance implies an annual growth ra...
- SpaceX IPO a bid too far? Some opt for a proxy play with Inox IndiaInox India shares surged following reports of a massively oversubscribed SpaceX IPO, drawing investor attention to the Indian company as a ...
- Betting big on mid and smallcaps; largecaps most expensive on PEG basis, says Dinshaw IraniHelios Mutual Fund is shifting investments from large companies to mid and small companies. This move follows earnings growth trends where ...
- PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
Load More
